NR

Nimmalagadda Rama Gopal

Active Director Director DIN 08402317
DIN 08402317 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nimmalagadda Rama Gopal

Data last updated:

Nimmalagadda Rama Gopal is a Director at Virtuso Pharmaceutical Industries Private Limited (since 2019). The company operates in Pharma.

DIN 08402317
Primary Designation Director
Industry Pharma
First Appointment 27 Mar 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20192019Active

Board colleagues of Nimmalagadda Rama Gopal

NameDINCompanyDesignation
Sirisha Nimmalagadda08402316Virtuso Pharmaceutical Industries Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Virtuso Pharmaceutical Industries Private Limited
Premium access

Shareholding and investment profile for Nimmalagadda Rama Gopal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimmalagadda Rama Gopal

Nimmalagadda Rama Gopal currently holds 1 directorship: Virtuso Pharmaceutical Industries Private Limited (Director, since 27 Mar 2019).

Nimmalagadda Rama Gopal was first appointed on 27 Mar 2019 as Director at Virtuso Pharmaceutical Industries Private Limited.

The current boards of Nimmalagadda Rama Gopal's companies include Sirisha Nimmalagadda (Virtuso Pharmaceutical Industries Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available